Oncotype DX Bladder Cancer Assay

The Oncotype DX Bladder Cancer Assay is a diagnostic test that analyzes specific gene patterns in a bladder cancer tumor to predict the likelihood of the cancer returning or progressing. By examining the tumor's genetic information, it helps doctors determine the best treatment approach, such as whether to pursue more aggressive therapy or monitor the patient closely. This test aids in personalized decision-making, improving the management and outcomes for bladder cancer patients.